Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
PhenoMiner Database Result        View data table  |  Download data table  |  View expanded data table        


Generate Chart For    
    (Chart displayed below)
Rat Strains

{{sample.term}}
Measurement Methods

{{method.term}}
Age

{{ageRange}}
Experimental Conditions

     {{ cond }}

Minimum Value:    Maximum Value:    Sex:


 
Options:  View chart  |  Download data table  |  View expanded data table
# of AnimalsPhenotypeStrainSexValueUnitsConditionsRecord IDCondition 1Condition 2aCondition 2bCondition 3Condition 4
11methylene blue metabolism-surface area product without auto-oxidationSS-Chr 3BN/Mcwimale19.7277ml/min/kgair oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours)57856air oxygen content (12 %) (for 14 days)methylene blue (10 umol/l) (between 0 and 0 hours)
12methylene blue metabolism-surface area product without auto-oxidationSS-Chr 3BN/Mcwifemale25.3167ml/min/kgair oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours)57861air oxygen content (12 %) (for 14 days)methylene blue (10 umol/l) (between 0 and 0 hours)
11methylene blue metabolism-surface area product after auto-oxidationSS-Chr 3BN/Mcwimale13.4283ml/min/kgair oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) then sample resting period (for 0.1 hours)57654air oxygen content (12 %) (for 14 days)methylene blue (10 umol/l) (between 0 and 0 hours)sample resting period (for 0.1 hours)
12methylene blue metabolism-surface area product after auto-oxidationSS-Chr 3BN/Mcwifemale14.9432ml/min/kgair oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) then sample resting period (for 0.1 hours)57659air oxygen content (12 %) (for 14 days)methylene blue (10 umol/l) (between 0 and 0 hours)sample resting period (for 0.1 hours)
10heart wet weightSS-Chr 3BN/Mcwimale0.622gair oxygen content (12 %) (for 14 days)45460air oxygen content (12 %) (for 14 days)
10heart wet weightSS-Chr 3BN/Mcwifemale0.749gair oxygen content (12 %) (for 14 days)45465air oxygen content (12 %) (for 14 days)
12percent change in respiration rateSS-Chr 3BN/Mcwimale117.1248%air oxygen content (12 %) (between 0 and 0.1 hours)54382air oxygen content (12 %) (between 0 and 0.1 hours)
11percent change in respiration rateSS-Chr 3BN/Mcwifemale124.5128%air oxygen content (12 %) (between 0 and 0.1 hours)54387air oxygen content (12 %) (between 0 and 0.1 hours)
8arterial blood flow rateSS-Chr 3BN/Mcwimale5.3275ml/min/gair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)44773air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
10arterial blood flow rateSS-Chr 3BN/Mcwifemale4.298ml/min/gair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)44778air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
8heart rateSS-Chr 3BN/Mcwimale228.1675beats/minair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)45203air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
10heart rateSS-Chr 3BN/Mcwifemale201.828beats/minair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)45208air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
9left ventricular developed pressureSS-Chr 3BN/Mcwimale22.7289mmHgair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)45325air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
10left ventricular developed pressureSS-Chr 3BN/Mcwifemale30.006mmHgair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)45330air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
9left ventricular systolic blood pressureSS-Chr 3BN/Mcwimale78.9156mmHgair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)49943air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
10left ventricular systolic blood pressureSS-Chr 3BN/Mcwifemale89.041mmHgair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)49948air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
9heart contraction pressureSS-Chr 3BN/Mcwimale28mmHgair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours)50052air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)
10heart contraction pressureSS-Chr 3BN/Mcwifemale34.5mmHgair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours)50057air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)
9time to peak heart contractionSS-Chr 3BN/Mcwimale1046.2222sair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours)50282air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)
10time to peak heart contractionSS-Chr 3BN/Mcwifemale1134.3sair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours)50287air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)
10body weightSS-Chr 3BN/Mcwimale117.1gair oxygen content (12 %) (for 14 days)49536air oxygen content (12 %) (for 14 days)
10body weightSS-Chr 3BN/Mcwifemale122.4gair oxygen content (12 %) (for 14 days)49542air oxygen content (12 %) (for 14 days)
8heart left ventricle infarction weight to total heart left ventricle weight ratioSS-Chr 3BN/Mcwimale20.92%air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours)49753air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 3 hours)
9heart left ventricle infarction weight to total heart left ventricle weight ratioSS-Chr 3BN/Mcwifemale11.0878%air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours)49758air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 3 hours)
6time to onset of heart contractionSS-Chr 3BN/Mcwimale844.8333sair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours)49354air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)
10time to onset of heart contractionSS-Chr 3BN/Mcwifemale932.6sair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours)49359air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)
11percent change in ventilationSS-Chr 3BN/Mcwifemale131.3803%air oxygen content (12 %) (between 0 and 0.1 hours)13742air oxygen content (12 %) (between 0 and 0.1 hours)
12percent change in tidal volumeSS-Chr 3BN/Mcwimale113.7317%air oxygen content (12 %) (between 0 and 0.1 hours)53941air oxygen content (12 %) (between 0 and 0.1 hours)
11percent change in tidal volumeSS-Chr 3BN/Mcwifemale109.665%air oxygen content (12 %) (between 0 and 0.1 hours)53946air oxygen content (12 %) (between 0 and 0.1 hours)
12percent change in tidal volumeSS-Chr 3BN/Mcwimale110.0498%air oxygen content (12 %) (between 0.1 and 0.1 hours)54042air oxygen content (12 %) (between 0.1 and 0.1 hours)
11percent change in tidal volumeSS-Chr 3BN/Mcwifemale104.2804%air oxygen content (12 %) (between 0.1 and 0.1 hours)54047air oxygen content (12 %) (between 0.1 and 0.1 hours)
7serum alkaline phosphatase activity levelSS-Chr 3BN/Mcwimale251.2857U/lair oxygen content (12 %) (for 14 days)36435air oxygen content (12 %) (for 14 days)
6serum alkaline phosphatase activity levelSS-Chr 3BN/Mcwifemale199.1667U/lair oxygen content (12 %) (for 14 days)36440air oxygen content (12 %) (for 14 days)
15heart right ventricle weight to left ventricle weight ratioSS-Chr 3BN/Mcwimale0.433air oxygen content (12 %) (for 14 days)58789air oxygen content (12 %) (for 14 days)
14heart right ventricle weight to left ventricle weight ratioSS-Chr 3BN/Mcwifemale0.4067air oxygen content (12 %) (for 14 days)58794air oxygen content (12 %) (for 14 days)
4absolute change in blood pHSS-Chr 3BN/Mcwimale0.0419air oxygen content (12 %) (for 0.1 hours)19790air oxygen content (12 %) (for 0.1 hours)
2absolute change in blood pHSS-Chr 3BN/Mcwifemale0.003air oxygen content (12 %) (for 0.1 hours)19796air oxygen content (12 %) (for 0.1 hours)
15body weightSS-Chr 3BN/Mcwimale184gair oxygen content (12 %) (for 14 days)59118air oxygen content (12 %) (for 14 days)
14body weightSS-Chr 3BN/Mcwifemale131gair oxygen content (12 %) (for 14 days)59123air oxygen content (12 %) (for 14 days)
7hematocritSS-Chr 3BN/Mcwimale52.2571%air oxygen content (12 %) (for 14 days)59313air oxygen content (12 %) (for 14 days)
7hematocritSS-Chr 3BN/Mcwifemale48.0714%air oxygen content (12 %) (for 14 days)59318air oxygen content (12 %) (for 14 days)
14calculated pulmonary vascular resistance normalized to body weightSS-Chr 3BN/Mcwimale0.1288mmHg x min x kg x ml-1air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours)59603air oxygen content (12 %) (for 14 days)Kreb's solution perfusate (between 0.2 and 0.2 hours)
12calculated pulmonary vascular resistance normalized to body weightSS-Chr 3BN/Mcwifemale0.1208mmHg x min x kg x ml-1air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours)59608air oxygen content (12 %) (for 14 days)Kreb's solution perfusate (between 0.2 and 0.2 hours)
15lung dry weight to body weight ratioSS-Chr 3BN/Mcwimale1.375g/kgair oxygen content (12 %) (for 14 days)59713air oxygen content (12 %) (for 14 days)
12lung dry weight to body weight ratioSS-Chr 3BN/Mcwifemale1.4499g/kgair oxygen content (12 %) (for 14 days)59718air oxygen content (12 %) (for 14 days)
11dose of methacholine at which pulmonary conductance is half its pretreatment valueSS-Chr 3BN/Mcwimale1.197mg/kgair oxygen content (12 %) (for 14 days) then methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours)58962air oxygen content (12 %) (for 14 days)methacholine (0-11.06 mg/kg) drug dose time series (for 0.2 hours)
6dose of methacholine at which pulmonary conductance is half its pretreatment valueSS-Chr 3BN/Mcwifemale1.5063mg/kgair oxygen content (12 %) (for 14 days) then methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours)58967air oxygen content (12 %) (for 14 days)methacholine (0-11.06 mg/kg) drug dose time series (for 0.2 hours)
14fractional change in blood vessel diameter per unit change in intravascular pressureSS-Chr 3BN/Mcwimale0.035mmHg-1air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours)58545air oxygen content (12 %) (for 14 days)Kreb's solution perfusate (between 0.2 and 0.2 hours)
12fractional change in blood vessel diameter per unit change in intravascular pressureSS-Chr 3BN/Mcwifemale0.0252mmHg-1air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours)58550air oxygen content (12 %) (for 14 days)Kreb's solution perfusate (between 0.2 and 0.2 hours)
7mean corpuscular hemoglobinSS-Chr 3BN/Mcwimale18.9857pgair oxygen content (12 %) (for 14 days)42601air oxygen content (12 %) (for 14 days)
7mean corpuscular hemoglobinSS-Chr 3BN/Mcwifemale18.9571pgair oxygen content (12 %) (for 14 days)42606air oxygen content (12 %) (for 14 days)
7serum chloride levelSS-Chr 3BN/Mcwimale109.1429mmol/lair oxygen content (12 %) (for 14 days)39173air oxygen content (12 %) (for 14 days)
6serum chloride levelSS-Chr 3BN/Mcwifemale109.5mmol/lair oxygen content (12 %) (for 14 days)39178air oxygen content (12 %) (for 14 days)
7serum urea nitrogen levelSS-Chr 3BN/Mcwimale23.4286mg/dlair oxygen content (12 %) (for 14 days)40884air oxygen content (12 %) (for 14 days)
6serum urea nitrogen levelSS-Chr 3BN/Mcwifemale30.6667mg/dlair oxygen content (12 %) (for 14 days)40889air oxygen content (12 %) (for 14 days)
7red blood cell countSS-Chr 3BN/Mcwimale8.9386x 10E6 cells/ulair oxygen content (12 %) (for 14 days)39293air oxygen content (12 %) (for 14 days)
7red blood cell countSS-Chr 3BN/Mcwifemale8.1157x 10E6 cells/ulair oxygen content (12 %) (for 14 days)39298air oxygen content (12 %) (for 14 days)
7total white blood cell countSS-Chr 3BN/Mcwimale7.2286x 1000 cells/ulair oxygen content (12 %) (for 14 days)40982air oxygen content (12 %) (for 14 days)
7total white blood cell countSS-Chr 3BN/Mcwifemale5.5571x 1000 cells/ulair oxygen content (12 %) (for 14 days)40987air oxygen content (12 %) (for 14 days)
7serum aspartate aminotransferase activity levelSS-Chr 3BN/Mcwimale88.2857U/lair oxygen content (12 %) (for 14 days)42826air oxygen content (12 %) (for 14 days)
6serum aspartate aminotransferase activity levelSS-Chr 3BN/Mcwifemale67.8333U/lair oxygen content (12 %) (for 14 days)42831air oxygen content (12 %) (for 14 days)
7serum sodium levelSS-Chr 3BN/Mcwimale144mmol/lair oxygen content (12 %) (for 14 days)39444air oxygen content (12 %) (for 14 days)
6serum sodium levelSS-Chr 3BN/Mcwifemale144.5mmol/lair oxygen content (12 %) (for 14 days)39449air oxygen content (12 %) (for 14 days)
7serum phosphate levelSS-Chr 3BN/Mcwimale9.5571mg/dlair oxygen content (12 %) (for 14 days)37650air oxygen content (12 %) (for 14 days)
6serum phosphate levelSS-Chr 3BN/Mcwifemale11.2667mg/dlair oxygen content (12 %) (for 14 days)37655air oxygen content (12 %) (for 14 days)
7blood neutrophil countSS-Chr 3BN/Mcwimale0.7814x 1000 cells/ulair oxygen content (12 %) (for 14 days)43280air oxygen content (12 %) (for 14 days)
7blood neutrophil countSS-Chr 3BN/Mcwifemale0.7586x 1000 cells/ulair oxygen content (12 %) (for 14 days)43285air oxygen content (12 %) (for 14 days)
7plasma creatinine levelSS-Chr 3BN/Mcwimale0.3143mg/dlair oxygen content (12 %) (for 14 days)39632air oxygen content (12 %) (for 14 days)
6plasma creatinine levelSS-Chr 3BN/Mcwifemale0.4333mg/dlair oxygen content (12 %) (for 14 days)39637air oxygen content (12 %) (for 14 days)
12FAPGG metabolism-surface area productSS-Chr 3BN/Mcwimale47.5633ml/min/kgair oxygen content (12 %) (for 14 days) then FAPGG (0.6 mmol/l) (between 0 and 0 hours)58055air oxygen content (12 %) (for 14 days)FAPGG (0.6 mmol/l) (between 0 and 0 hours)
11FAPGG metabolism-surface area productSS-Chr 3BN/Mcwifemale60.8272ml/min/kgair oxygen content (12 %) (for 14 days) then FAPGG (0.6 mmol/l) (between 0 and 0 hours)58060air oxygen content (12 %) (for 14 days)FAPGG (0.6 mmol/l) (between 0 and 0 hours)
7blood monocyte countSS-Chr 3BN/Mcwimale0.32x 1000 cells/ulair oxygen content (12 %) (for 14 days)39730air oxygen content (12 %) (for 14 days)
7blood monocyte countSS-Chr 3BN/Mcwifemale0.2029x 1000 cells/ulair oxygen content (12 %) (for 14 days)39735air oxygen content (12 %) (for 14 days)
7blood hemoglobin levelSS-Chr 3BN/Mcwimale16.9571g/dlair oxygen content (12 %) (for 14 days)38024air oxygen content (12 %) (for 14 days)
7blood hemoglobin levelSS-Chr 3BN/Mcwifemale15.3857g/dlair oxygen content (12 %) (for 14 days)38029air oxygen content (12 %) (for 14 days)
7mean corpuscular hemoglobin concentrationSS-Chr 3BN/Mcwimale32.4714g/dlair oxygen content (12 %) (for 14 days)39833air oxygen content (12 %) (for 14 days)
7mean corpuscular hemoglobin concentrationSS-Chr 3BN/Mcwifemale31.9571g/dlair oxygen content (12 %) (for 14 days)39838air oxygen content (12 %) (for 14 days)
7blood lymphocyte countSS-Chr 3BN/Mcwimale6.12x 1000 cells/ulair oxygen content (12 %) (for 14 days)41559air oxygen content (12 %) (for 14 days)
7blood lymphocyte countSS-Chr 3BN/Mcwifemale4.58x 1000 cells/ulair oxygen content (12 %) (for 14 days)41564air oxygen content (12 %) (for 14 days)
7serum potassium levelSS-Chr 3BN/Mcwimale5.4714mmol/lair oxygen content (12 %) (for 14 days)38122air oxygen content (12 %) (for 14 days)
6serum potassium levelSS-Chr 3BN/Mcwifemale4.3167mmol/lair oxygen content (12 %) (for 14 days)38127air oxygen content (12 %) (for 14 days)
7blood eosinophil countSS-Chr 3BN/Mcwimale0.0086x 1000 cells/ulair oxygen content (12 %) (for 14 days)41703air oxygen content (12 %) (for 14 days)
7blood eosinophil countSS-Chr 3BN/Mcwifemale0.0143x 1000 cells/ulair oxygen content (12 %) (for 14 days)41708air oxygen content (12 %) (for 14 days)
10methylene blue to FAPGG metabolism-surface area product ratioSS-Chr 3BN/Mcwimale0.4702air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours)58169air oxygen content (12 %) (for 14 days)methylene blue (10 umol/l) (between 0 and 0 hours)
11methylene blue to FAPGG metabolism-surface area product ratioSS-Chr 3BN/Mcwifemale0.4333air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours)58174air oxygen content (12 %) (for 14 days)methylene blue (10 umol/l) (between 0 and 0 hours)
7plasma anion gapSS-Chr 3BN/Mcwimale18.7143mmol/lair oxygen content (12 %) (for 14 days)38317air oxygen content (12 %) (for 14 days)
6plasma anion gapSS-Chr 3BN/Mcwifemale19mmol/lair oxygen content (12 %) (for 14 days)38322air oxygen content (12 %) (for 14 days)
7serum total bilirubin levelSS-Chr 3BN/Mcwimale0.1mg/dlair oxygen content (12 %) (for 14 days)41924air oxygen content (12 %) (for 14 days)
6serum total bilirubin levelSS-Chr 3BN/Mcwifemale0.15mg/dlair oxygen content (12 %) (for 14 days)41929air oxygen content (12 %) (for 14 days)
7serum calcium levelSS-Chr 3BN/Mcwimale9.1mg/dlair oxygen content (12 %) (for 14 days)36680air oxygen content (12 %) (for 14 days)
6serum calcium levelSS-Chr 3BN/Mcwifemale9.4833mg/dlair oxygen content (12 %) (for 14 days)36685air oxygen content (12 %) (for 14 days)
7serum glucose levelSS-Chr 3BN/Mcwimale138.2857mg/dlair oxygen content (12 %) (for 14 days)38586air oxygen content (12 %) (for 14 days)
6serum glucose levelSS-Chr 3BN/Mcwifemale154.3333mg/dlair oxygen content (12 %) (for 14 days)38591air oxygen content (12 %) (for 14 days)
7serum bicarbonate levelSS-Chr 3BN/Mcwimale21.5714mmol/lair oxygen content (12 %) (for 14 days)42118air oxygen content (12 %) (for 14 days)
6serum bicarbonate levelSS-Chr 3BN/Mcwifemale20.1667mmol/lair oxygen content (12 %) (for 14 days)42123air oxygen content (12 %) (for 14 days)
7serum globulin levelSS-Chr 3BN/Mcwimale1.7g/dlair oxygen content (12 %) (for 14 days)40606air oxygen content (12 %) (for 14 days)
6serum globulin levelSS-Chr 3BN/Mcwifemale1.5g/dlair oxygen content (12 %) (for 14 days)40611air oxygen content (12 %) (for 14 days)
7serum albumin levelSS-Chr 3BN/Mcwimale3.8571g/dlair oxygen content (12 %) (for 14 days)42289air oxygen content (12 %) (for 14 days)
6serum albumin levelSS-Chr 3BN/Mcwifemale3.7667g/dlair oxygen content (12 %) (for 14 days)42294air oxygen content (12 %) (for 14 days)
7serum total protein levelSS-Chr 3BN/Mcwimale5.5571g/dlair oxygen content (12 %) (for 14 days)37018air oxygen content (12 %) (for 14 days)
6serum total protein levelSS-Chr 3BN/Mcwifemale5.2667g/dlair oxygen content (12 %) (for 14 days)37023air oxygen content (12 %) (for 14 days)
7mean corpuscular volumeSS-Chr 3BN/Mcwimale58.4714flair oxygen content (12 %) (for 14 days)38801air oxygen content (12 %) (for 14 days)
7mean corpuscular volumeSS-Chr 3BN/Mcwifemale59.3286flair oxygen content (12 %) (for 14 days)38806air oxygen content (12 %) (for 14 days)
7serum total cholesterol levelSS-Chr 3BN/Mcwimale76.7143mg/dlair oxygen content (12 %) (for 14 days)37153air oxygen content (12 %) (for 14 days)
6serum total cholesterol levelSS-Chr 3BN/Mcwifemale84.6667mg/dlair oxygen content (12 %) (for 14 days)37158air oxygen content (12 %) (for 14 days)
7serum alanine aminotransferase activity levelSS-Chr 3BN/Mcwimale58.7143U/lair oxygen content (12 %) (for 14 days)40770air oxygen content (12 %) (for 14 days)
6serum alanine aminotransferase activity levelSS-Chr 3BN/Mcwifemale50.6667U/lair oxygen content (12 %) (for 14 days)40775air oxygen content (12 %) (for 14 days)
7hematocritSS-Chr 3BN/Mcwimale52.2571%air oxygen content (12 %) (for 14 days)39047air oxygen content (12 %) (for 14 days)
7hematocritSS-Chr 3BN/Mcwifemale48.0714%air oxygen content (12 %) (for 14 days)39052air oxygen content (12 %) (for 14 days)
8arterial blood flow rateSS-Chr 3BN/Mcwimale10.4075ml/min/gair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours)46708air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)
10arterial blood flow rateSS-Chr 3BN/Mcwifemale9.119ml/min/gair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours)46713air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)
9left ventricular diastolic blood pressureSS-Chr 3BN/Mcwimale4.8611mmHgair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours)47252air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)
10left ventricular diastolic blood pressureSS-Chr 3BN/Mcwifemale6.308mmHgair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours)47257air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)
8percent change in heart rateSS-Chr 3BN/Mcwimale88.2522%air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)48350air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
9percent change in heart rateSS-Chr 3BN/Mcwifemale78.7347%air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)48355air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
9percent change in left ventricular developed pressureSS-Chr 3BN/Mcwimale26.2141%air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)48582air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
9percent change in left ventricular developed pressureSS-Chr 3BN/Mcwifemale32.478%air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)48587air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
9left ventricular developed pressureSS-Chr 3BN/Mcwimale87.2244mmHgair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours)48679air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)
10left ventricular developed pressureSS-Chr 3BN/Mcwifemale81.85mmHgair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours)48684air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)
9percent change in left ventricular systolic blood pressureSS-Chr 3BN/Mcwimale86.8798%air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)48811air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
9percent change in left ventricular systolic blood pressureSS-Chr 3BN/Mcwifemale96.2787%air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)48816air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
12respiration rateSS-Chr 3BN/Mcwimale120.9922breaths/minair oxygen content (12 %) (between 0 and 0.1 hours)18322air oxygen content (12 %) (between 0 and 0.1 hours)
11respiration rateSS-Chr 3BN/Mcwifemale111.214breaths/minair oxygen content (12 %) (between 0 and 0.1 hours)18327air oxygen content (12 %) (between 0 and 0.1 hours)
12percent change in respiration rateSS-Chr 3BN/Mcwimale107.1162%air oxygen content (12 %) (between 0.1 and 0.1 hours)53809air oxygen content (12 %) (between 0.1 and 0.1 hours)
11percent change in respiration rateSS-Chr 3BN/Mcwifemale123.7697%air oxygen content (12 %) (between 0.1 and 0.1 hours)53814air oxygen content (12 %) (between 0.1 and 0.1 hours)
12body temperatureSS-Chr 3BN/Mcwimale37.3583degrees Cair oxygen content (12 %) (for 0.1 hours)16629air oxygen content (12 %) (for 0.1 hours)
11body temperatureSS-Chr 3BN/Mcwifemale37.2727degrees Cair oxygen content (12 %) (for 0.1 hours)16634air oxygen content (12 %) (for 0.1 hours)
10heart weight to body weight ratioSS-Chr 3BN/Mcwimale5.388g/kgair oxygen content (12 %) (for 14 days)45634air oxygen content (12 %) (for 14 days)
10heart weight to body weight ratioSS-Chr 3BN/Mcwifemale6.187g/kgair oxygen content (12 %) (for 14 days)45640air oxygen content (12 %) (for 14 days)
8heart effluent lactate dehydrogenase activity level normalized to heart weightSS-Chr 3BN/Mcwimale0.5272IU/gair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours)47462air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)
10heart effluent lactate dehydrogenase activity level normalized to heart weightSS-Chr 3BN/Mcwifemale0.3942IU/gair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours)47467air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)
9left ventricular systolic blood pressureSS-Chr 3BN/Mcwimale92.0856mmHgair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours)45784air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)
10left ventricular systolic blood pressureSS-Chr 3BN/Mcwifemale88.158mmHgair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours)45789air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)
9left ventricular diastolic blood pressureSS-Chr 3BN/Mcwimale56.1867mmHgair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)46472air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
10left ventricular diastolic blood pressureSS-Chr 3BN/Mcwifemale59.035mmHgair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)46477air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
9heart rateSS-Chr 3BN/Mcwimale257.1389beats/minair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours)47637air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)
9heart rateSS-Chr 3BN/Mcwifemale268.88beats/minair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours)47642air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)
8percent change in arterial blood flow rateSS-Chr 3BN/Mcwimale55.2181%air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)47132air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
10percent change in arterial blood flow rateSS-Chr 3BN/Mcwifemale48.9898%air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours)47137air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 0.7 hours)
8heart effluent lactate dehydrogenase activity level normalized to heart weightSS-Chr 3BN/Mcwimale18.6205IU/gair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours)45978air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 1.5 hours)
10heart effluent lactate dehydrogenase activity level normalized to heart weightSS-Chr 3BN/Mcwifemale15.7838IU/gair oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours)45983air oxygen content (12 %) (for 14 days)controlled oxygen content Kreb's solution perfusate (for 0.5 hours)perfusate suspended (for 0.4 hours)controlled oxygen content Kreb's solution perfusate (for 1.5 hours)
4absolute change in partial pressure of blood oxygenSS-Chr 3BN/Mcwimale-41.7mmHgair oxygen content (12 %) (for 0.1 hours)19469air oxygen content (12 %) (for 0.1 hours)
2absolute change in partial pressure of blood oxygenSS-Chr 3BN/Mcwifemale-58.5mmHgair oxygen content (12 %) (for 0.1 hours)19475air oxygen content (12 %) (for 0.1 hours)
6blood pHSS-Chr 3BN/Mcwimale7.4956air oxygen content (12 %) (for 0.1 hours)17054air oxygen content (12 %) (for 0.1 hours)
2blood pHSS-Chr 3BN/Mcwifemale7.5155air oxygen content (12 %) (for 0.1 hours)17060air oxygen content (12 %) (for 0.1 hours)
12tidal volumeSS-Chr 3BN/Mcwimale0.3613mlair oxygen content (12 %) (between 0 and 0.1 hours)13980air oxygen content (12 %) (between 0 and 0.1 hours)
11tidal volumeSS-Chr 3BN/Mcwifemale0.2935mlair oxygen content (12 %) (between 0 and 0.1 hours)13985air oxygen content (12 %) (between 0 and 0.1 hours)
11minute ventilationSS-Chr 3BN/Mcwifemale32.3565ml/minair oxygen content (12 %) (between 0 and 0.1 hours)18724air oxygen content (12 %) (between 0 and 0.1 hours)
5mean arterial blood pressureSS-Chr 3BN/Mcwimale127.738mmHgair oxygen content (12 %) (for 0.1 hours)14336air oxygen content (12 %) (for 0.1 hours)
5mean arterial blood pressureSS-Chr 3BN/Mcwifemale140.788mmHgair oxygen content (12 %) (for 0.1 hours)14342air oxygen content (12 %) (for 0.1 hours)
12respiration rateSS-Chr 3BN/Mcwimale110.9289breaths/minair oxygen content (12 %) (between 0.1 and 0.1 hours)14851air oxygen content (12 %) (between 0.1 and 0.1 hours)
11respiration rateSS-Chr 3BN/Mcwifemale111.2997breaths/minair oxygen content (12 %) (between 0.1 and 0.1 hours)14856air oxygen content (12 %) (between 0.1 and 0.1 hours)
12tidal volumeSS-Chr 3BN/Mcwimale0.3498mlair oxygen content (12 %) (between 0.1 and 0.1 hours)15290air oxygen content (12 %) (between 0.1 and 0.1 hours)
11tidal volumeSS-Chr 3BN/Mcwifemale0.2786mlair oxygen content (12 %) (between 0.1 and 0.1 hours)15295air oxygen content (12 %) (between 0.1 and 0.1 hours)
12percent change in ventilationSS-Chr 3BN/Mcwimale131.7056%air oxygen content (12 %) (between 0 and 0.1 hours)13737air oxygen content (12 %) (between 0 and 0.1 hours)
4absolute change in partial pressure of blood carbon dioxideSS-Chr 3BN/Mcwimale-5mmHgair oxygen content (12 %) (for 0.1 hours)19638air oxygen content (12 %) (for 0.1 hours)
12minute ventilationSS-Chr 3BN/Mcwimale37.9342ml/minair oxygen content (12 %) (between 0.1 and 0.1 hours)20265air oxygen content (12 %) (between 0.1 and 0.1 hours)
11minute ventilationSS-Chr 3BN/Mcwifemale30.8552ml/minair oxygen content (12 %) (between 0.1 and 0.1 hours)20270air oxygen content (12 %) (between 0.1 and 0.1 hours)
2absolute change in partial pressure of blood carbon dioxideSS-Chr 3BN/Mcwifemale-6.65mmHgair oxygen content (12 %) (for 0.1 hours)19644air oxygen content (12 %) (for 0.1 hours)
6partial pressure of blood carbon dioxide (Pco2)SS-Chr 3BN/Mcwimale29.25mmHgair oxygen content (12 %) (for 0.1 hours)17246air oxygen content (12 %) (for 0.1 hours)
2partial pressure of blood carbon dioxide (Pco2)SS-Chr 3BN/Mcwifemale26.75mmHgair oxygen content (12 %) (for 0.1 hours)17252air oxygen content (12 %) (for 0.1 hours)
5heart rateSS-Chr 3BN/Mcwimale400.208beats/minair oxygen content (12 %) (for 0.1 hours)17509air oxygen content (12 %) (for 0.1 hours)
5heart rateSS-Chr 3BN/Mcwifemale406.64beats/minair oxygen content (12 %) (for 0.1 hours)17515air oxygen content (12 %) (for 0.1 hours)
12absolute change in body temperatureSS-Chr 3BN/Mcwimale0.1083degrees Cair oxygen content (12 %) (for 0.1 hours)20366air oxygen content (12 %) (for 0.1 hours)
11absolute change in body temperatureSS-Chr 3BN/Mcwifemale-0.1545degrees Cair oxygen content (12 %) (for 0.1 hours)20371air oxygen content (12 %) (for 0.1 hours)
12minute ventilationSS-Chr 3BN/Mcwimale43.2442ml/minair oxygen content (12 %) (between 0 and 0.1 hours)18719air oxygen content (12 %) (between 0 and 0.1 hours)
6partial pressure of blood oxygenSS-Chr 3BN/Mcwimale61.7167mmHgair oxygen content (12 %) (for 0.1 hours)20481air oxygen content (12 %) (for 0.1 hours)
2partial pressure of blood oxygenSS-Chr 3BN/Mcwifemale61.05mmHgair oxygen content (12 %) (for 0.1 hours)20487air oxygen content (12 %) (for 0.1 hours)